நிறுவனம் முதலீட்டாளர் நிகழ்வுகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நிறுவனம் முதலீட்டாளர் நிகழ்வுகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நிறுவனம் முதலீட்டாளர் நிகழ்வுகள் Today - Breaking & Trending Today

Orgenesis Second Quarter 2021 Revenue Increases Over

Orgenesis to host conference call today at 8:30AM ET. ....

New York , United States , Hospital For Special Surgery , Genesi Icellator , David Waldman , Neil Hunter Michelle Boxall , Vered Caplan , Johns Hopkins University , Exchange Commission On , Crescendo Communications , Orgenesis Inc , Image Box Communications , Exchange Commission , Company Form , Company Investor Events , Pocare Technology , Pocare Network , North America , Tissue Genesis , Special Surgery , Tissue Genesi Icellator , Orgenesis Mobile Processing Units , Tamir Biotechnology , Investor Events , Orgenesis Point , Care Platform ,

Orgenesis Provides Fiscal 2020 Year-End Results and Corporate Update; Expands POCare Therapeutic Pipeline, POCare Technologies, and POCare Network

Share:
Revenue increases 96% to $7.7 million for 2020
Projects to more than double in revenue for 2021 based on current contracts already in hand
Orgenesis to host conference call today at 8:30AM ET
GERMANTOWN, Md., March 09, 2021 (GLOBE NEWSWIRE)
. (NASDAQ:ORGS) ( Orgenesis or the Company ), a global biotech company working to unlock the full potential of cell and gene therapies (CGTs), today reported financial results for the year ended December 31, 2020 and provided a business update.
Vered Caplan, CEO of Orgenesis, commented, Just over a year ago, we completed the sale of one of our business divisions, which provided centralized manufacturing subcontracting services to cell and gene biotech companies. This activity was incorporated in the Masthercell subsidiary, a contract development manufacturing organization (CDMO). The CDMO was sold for $315 million, generating approximately $127 million of proceeds to Orgenesis. We determined it was the rig ....

United States , South Korea , Neil Hunter Michelle Boxall , Vered Caplan , Crescendo Communications , Orgenesis Inc , Image Box Communications , Exchange Commission , Company Investor Events , Pocare Technology , Pocare Network , Orgenesis Mobile Processing Units , Investor Events , Orgenesis Point , Care Platform , Securities Act , Exchange Act , Annual Report , Discontinued Operations , ஒன்றுபட்டது மாநிலங்களில் , தெற்கு கொரியா , பிறை தகவல்தொடர்புகள் , படம் பெட்டி தகவல்தொடர்புகள் , பரிமாற்றம் தரகு , நிறுவனம் முதலீட்டாளர் நிகழ்வுகள் , முதலீட்டாளர் நிகழ்வுகள் ,

Medexus Achieves Record Revenue of $31.5 Million for the Third Quarter Fiscal 2021

Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Medexus Achieves Record Revenue of $31.5 Million for the Third Quarter Fiscal 2021
Medexus Pharmaceuticals IncMarch 1, 2021 GMT
TORONTO, CHICAGO and MONTREAL, March 01, 2021 (GLOBE NEWSWIRE) Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) today announced its financial and operating results for the three and nine months ended December 31, 2020. All dollar amounts below are in Canadian dollars unless specified otherwise.
Third Quarter Fiscal 2021 Financial Highlights:
The Company achieved record revenue of $31.5 million for the three-month period ended December 31, 2020, versus $16.2 million for the same period last year. As previously reported, the revenue for the period included approximately $3 million in IXINITY® revenues, which were originally expected to be realized in September 2020, but were i ....

United States , Tina Byers , Roland Boivin , Aptevo Therapeutics Inc , Company Nasdaq , Aptevo Biotherapeutics , Medexus Pharmaceuticals , Company On , Medac Pharma Inc , Venture Exchange , Regulation Services Provider , Medexus Pharma Inc , Stifel Nicolaus Canada Inc , Crescendo Communications , Medexus Inc , Health Canada Special Access Program , Medexus Pharmaceuticals Inc , Company Investor Events , Raymond James Ltd , Health Canada , Customer Service , Quarter Fiscal , Adjusted Net , Chief Executive Officer , North American , Deal Public Offering ,